We are currently limited to 700 million shares, NP said another 100 million shares are free, but if 50 million is reserved for noteholders then in my opinion it is possible that the shareholders meeting should raise the number of shares to 800 million because it is difficult to go into commercialization of drug without stock reserve. TO is also a good option when we file a BLA and reach a deal. For the combo I would say 99.9% will certainly be accepted and then approved, but cancers are progressing very fast and if the results are still excellent only the sky is the limit.